MedTrace Logo

Acute Effects of Posterior Talar Glide Mobilization

NCT07493083 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-25

No results posted yet for this study

Summary

The aim of this study is to evaluate the acute effects of posterior talar glide mobilisation on dorsiflexion range of motion wieght bearing (measured using the Weight-Bearing Lunge Test) and walking speed, using a randomised, sham-controlled study design.

Conditions

  • Ankle Dorsiflexion
  • Mobilization
  • Walking Speed, Mesh id D000072797
  • Range of Motion

Interventions

OTHER

Posterior Talar Glide Mobilization

Movement Combined with Weight-Shifting Mobilisation The therapist applies a continuous posteroanterior gliding force to the tibia via the strap by shifting their weight backwards. This technique functionally mimics the posterior gliding mechanism of the talus. The patient is asked to perform a slow dorsiflexion to the end of their range of motion. During this, the therapist maintains the posterior gliding force on the talus. Once the end point is reached, the gliding force is maintained for 10 seconds. One set of 10 repetitions of mobilisation is performed. \- Movement Combined with Mobilisation Without Weight Shifting The participant lies supine with the tibia in contact with the treatment table, whilst the foot and ankle are left free at the edge of the table. The ankle is stabilised with a non-elastic band, and the therapist applies posterior glide to the talus.

OTHER

Sham Group

Both mobilisation techniques and positions were explained to the participants; however, although the therapist assumed the glide position, no sliding movement was performed, and the participants were held in that position for 10 seconds. Posterior talar glide mobilisation and dorsiflexion measurements were performed on both the affected and unaffected ankles. All measurements will be repeated three times each-before and after treatment-and the average values will be recorded.

Sponsors & Collaborators

  • Hasan Kalyoncu University

    lead OTHER

Principal Investigators

  • Tuğba GÖNEN, Asisst. Prof. Dr. · Hasan Kalyoncu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2026-04-30
Completion
2026-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07493083 on ClinicalTrials.gov